MDS Podcast

Dr. Sarah Lidstone interviews Dr. Chang-Qing Gao & Prof. Ji-fung Guo about their recent research on the sensitivity of sniffer dogs for diagnosing Parkinson's disease. Read the article.

Members of the task force for Axial Postural Abnormalities in Parkinsonism, Prof. Tinazzi, Dr. Geroin and Dr. Artusi, discuss new nosology and cut-off values. Read the article.

Dr. Sara Schaefer discusses with Prof. Richard Smeyne how viruses including COVID-19 increase the susceptibility to oxidative stress-induced parkinsonism in mouse models, the historical evidence to support a virus-parkinsonism link, the biological basis for this correlation, and ways it may be prevented. Journal CME is available until July 29, 2023 Read the article.

New updates to MSA criteria and clinical evaluation tools will have a critical impact on MSA care and research. Dr. Maria Teresa Pellecchia discusses with Dr. Eduardo de Pablo-Fernández the next major areas of focus, and the progression of a variety of clinical trials.

Which emerging areas of movement disorders research are set to advance in the coming years? And how is that already beginning to affect clinical care? Prof. Jose Obeso shares about this and other key scienctific shifts with Prof. Tiago Outeiro.

Despite the challenge of studying rare conditions like PSP, Dr. Yaroslau Compta discusses with Dr. Eduardo de Pablo-Fernández how leaps forward in recent advances could make us rethink the way we approach the condition.

As genetics become more prominent in patient discussions, Professor Roy Alcalay outlines with Dr. Tiago Outeiro the key implications and opportunities as we enter "a different era of genetic testing."

Dr. Claudia Testa shares with Dr. Sara Schaefer why she believes in the quickly shifting field of tremor, we should be more open-minded about changes in diagnoses over time.

MDS President Francisco Cardoso shares with Dr. Michele Matarazzo the important takeaways from this year's Congress that will shape the future of movement disorders and the Society.

Dr. Ron Postuma outlines with Dr. Eduardo de Pablo-Fernández several advances this year he thinks will "revolutionize" Parkinson's disease care, and shifts the field may need to make as a whole to help us reach the next phase of prodromal and personalized treatments.